This site is intended for health professionals only
Friday 22 September 2017
Share |

Latest News

Once-daily single inhaler triple therapy receives positive opinion for appropriate patients with COPD

Monday 18th September 2017

GlaxoSmithKline and Innoviva, Inc have  announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending marketing authorisation for fluticasone furoate/ umeclidinium/vilanterol (FF/UMEC/VI) as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an inhaled corticosteroid and a...

Mon, 18 Sep 2017
Positive opinion follows the recent FDA approval of Cyltezo
Mon, 18 Sep 2017
More than 80% of patients receiving guselkumab, including patients transitioned from HUMIRA® (adalimumab) to the anti-interleukin (IL)-23 monoclonal antibody, demonstrated PASI 90 and IGA 0/1 scores at week 100
Thu, 14 Sep 2017
In people with type 2 diabetes, Xultophy® (insulin degludec/liraglutide) significantly reduced a number of risk factors associated with an increased risk of cardiovascular disease, compared to basal insulin
Thu, 14 Sep 2017
Romosozumab followed by alendronate reduced the incidence of new vertebral, clinical, non-vertebral and hip fractures compared to alendronate alone
Thu, 14 Sep 2017
An NTM lung infection can be a chronic and progressive condition that targets patients who are already struggling with pre-existing lung conditions, such as COPD, previous TB or bronchiectasis
Thu, 31 Aug 2017
Truberzi® now funded by the NHS, becomes the first IBS-D treatment reviewed and recommended by NICE in a Technology Appraisal Guidance
Tue, 29 Aug 2017
Tivozanib is indicated for the first line treatment of adult patients with advanced renal cell carcinoma and for adult patients who are VEGFR and mTOR pathway inhibitor-naïve following disease progression after one prior treatment with cytokine therapy for advanced RCC

You are leaving

You are currently leaving the Nursing in Practice site. Are you sure you want to proceed?


Respect for nurses: Sign up to our e-petition TODAY

The Nursing in Practice Respect campaign is now live! Over the coming months, we're set to highlight the vital contribution and efforts of primary care and community care nurses throughout the UK.

As part of our campaign, Nursing in Practice is looking to call on parliament to set up a debate to celebrate the vital work that you do.



Calling all primary care nurses! 'Like' our Nursing in Practice Facebook page to enter our free draw to win a £25 M&S voucher